We help patients in need of medication that is otherwise unavailable in their country. The timely access to unlicensed medicines is crucial to their treatment, and therefore healthcare providers value the professional, speedy and quality based service Specific Pharma is known for. Specific Pharma is also a preferred partner for pharmaceutical and biotechnological companies, which makes us part of a global network of medicinal knowledge for pharmacies and healthcare providers to tap into. More importantly, we are a reliable provider of unlicensed medicines and medicines for special purposes such as clinical trials and situations of drug shortage.
| Website | http://www.specificpharma.com |
| Revenue | $5.7 million |
| Employees | 38 (27 on RocketReach) |
| Founded | 2010 |
| Technologies |
JavaScript
,
HTML
,
PHP
+7 more
(view full list)
|
| Industry | Pharmaceutical Manufacturing |
| Keywords | Pharmaceutical Importation, Access To Medicine, International Pharmacy, Medicine Procurement, Global Drug Supply, Healthcare Logistics, Healthcare Supply Chain, Rare Disease Treatment, Patient Support Programs |
| Competitors | Roche, Novartis, Merck & Co., Inc., Sanofi, GSK, AstraZeneca, Bristol Myers Squibb, Teva Pharmaceuticals, Ferring Pharmaceuticals, Mylan Belgium +44 more (view full list) |
Looking for a particular Specific Pharma A/S employee's phone or email?
The Specific Pharma A/S annual revenue was $5.7 million in 2026.
Uffe Jensen is the CEO of Specific Pharma A/S.
27 people are employed at Specific Pharma A/S.